Implicit and Explicit Assessment of Suicide Risk
In 2007 Nock \& Banaji developed a so-called implicit suicide risk measurement using a computer tool: the Implicit Association Test (IAT). This measurement, associated with traditional evaluations, makes it possible to better predict suicidal recurrence. In 2020, the Poitiers team of Tello was able to replicate these r
| Condition(s) | Implicit Association Test, Suicide, Prevention, Suicide, Suicide Risk Factor |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | In 2007 Nock \& Banaji developed a so-called implicit suicide risk measurement using a computer tool: the Implicit Association Test (IAT). This measurement, associated with traditional evaluations, makes it possible to better predict suicidal recurrence. In 2020, the Poitiers team of Tello was able to replicate these results on a French population. However, although a high IAT score predicts the onset of suicide at 1 year, there is no data on how this score changes over time nor even data concerning the measure's ability to differentiate a population with explicit suicidal ideation from a population without explicit suicidal ideation. The investigators therefore seek to demonstrate an evolution of implicit suicidal ideation over time by replicating the measurement at inclusion, at 6 months |
| Who can participate | Inclusion Criteria: * Person presenting to emergencies for psychiatric reasons * Adult person * Free and informed consent signed * Person speaking and writing French fluently Exclusion Criteria: * Neurological disorders or major cognitive deterioration: presence of confusion * Acute psychotic decompensation * Troubled acute behavior * Abuse Impregnation of a toxic substance and / or drug impairing cognitive functions at the time of assessment * Adult under protective measure. |
| Ages | 18 Years |
| Sex | All |
| Lead sponsor | Centre Hospitalier Universitaire, Amiens |
| Locations | Amiens, Picardie, France |
| Start date | 2022-06-28 |
| NCT ID | NCT05903469 |
| Official listing | https://clinicaltrials.gov/study/NCT05903469 |